Today, the FDA and CDC issued a joint statement recommending a pause on the use of the Johnson & Johnson (J&J) COVID-19 vaccine following six reported US cases of a rare blood clotting event. These events are rare, and none have occurred in Connecticut.
Of 6.8 million individuals who have received the J&J vaccine nationally, six individuals have developed a rare and severe type of blood clot called cerebral venous sinus thrombosis (CVST) within two weeks of receiving their vaccine. All six cases occurred among women between ages 18–48 years. Roughly 100,000 Connecticut residents have received the J&J vaccine with no reported serious adverse events.
The Brookfield Health Department is a J & J Vaccine provider so until further investigation and information from the FDA and CDC is provided, we have put a pause on the delivery of the J & J vaccine at our vaccine clinics.
Brookfield will continue to offer appointments for the Moderna 1st and 2nd dose vaccine. All future appointments are for the Moderna vaccine so all appointments already made will remain the same as scheduled.
Visit the Town of Brookfield's Website for additional information.